Cyclopentylxanthine derivatives for use in the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/52 (2006.01) A61K 31/522 (2006.01) C07D 473/06 (2006.01)

Patent

CA 2270355

The use of derivatives of theophylline for the preparation of medicaments suitable for the treatment of Cystic Fibrosis is described. In particular, the use of 8-cyclopentyl theophylline (CPT) is described for the preparation of medicaments for the treatment of cystic fibrosis. Such medicaments may be administered orally or directly to the lung, for example, in the form of an aerosol.

L'invention porte sur l'utilisation de dérivés de la théophylline dans la préparation de médicaments utiles pour le traitement de la mucoviscidose. L'invention porte en particulier sur l'utilisation de 8-cyclopentyl-théophylline (CPT) dans la préparation de médicaments utiles pour le traitement de la mucoviscidose. De tels médicaments peuvent être administrés par voie orale ou directement dans les poumons, par exemple sous la forme d'un aérosol.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclopentylxanthine derivatives for use in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclopentylxanthine derivatives for use in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentylxanthine derivatives for use in the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1836146

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.